head-and-neck-cancer

Documents about head-and-neck-cancer

• A Study in Advanced Solid Tumors#825908ClinicalTrials.gov
• Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery#833609ClinicalTrials.gov
• A Study of Pembrolizumab in Combination With Chemotherapy for Head and Neck Cancer#160362ClinicalTrials.gov
• Phase III Trial Of Docetaxel Versus Docetaxel Plus ZD1839 In Head And Neck Cancer#857941ClinicalTrials.gov
• Phase II Trial of Allovectin-7® for Head and Neck Cancer#857005ClinicalTrials.gov
• PD-L1 t-haNK, NAI IL-15sa and Cetuximab for Recurrent, Metastatic HNSCC#902128ClinicalTrials.gov
• Commensal Oral Microbiota in Head and Neck Cancer#836837ClinicalTrials.gov
• Long Term Complications in Head and Neck Cancer Patients#978962ClinicalTrials.gov
• Nurse-led Exercise Improves Shoulder Pain, Shoulder Disability, and Quality of Life in Head and Neck Cancer#832208ClinicalTrials.gov
• Review of Palliative Radiotherapy in the Management of Advanced Head and Neck Cancer#813840ClinicalTrials.gov
• Study of ALE.C04 in Patients With Head and Neck Cancer#411399ClinicalTrials.gov
• Immunotherapy With MK-3475 in Surgically Resectable Head and Neck Squamous Cell Carcinoma#387157ClinicalTrials.gov
• Vaccine Therapy in Treating Patients With Head and Neck Cancer#249658ClinicalTrials.gov
• Head and Neck Cancer Omics/Integrated Precision Medicine (HOPE)#471452ClinicalTrials.gov
• Study of BKM120 in Advanced Squamous Cell Carcinoma of Head and Neck#880187ClinicalTrials.gov
• Heavy Strength Training in Head and Neck Cancer Survivors#903773ClinicalTrials.gov
• Decitabine and Nivolumab in Participants With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck#429741ClinicalTrials.gov
• A Study in Head and Neck Cancer#836817ClinicalTrials.gov
• Feasibility of Patient Selection and Treatment of Head-neck Cancer With Proton Therapy in Denmark#896782ClinicalTrials.gov
• Quick Diagnostic Program for Head and Neck Cancer#858105ClinicalTrials.gov
• FALCOn (Facteur AnthropoLogique Cancer Orl)#883295ClinicalTrials.gov
• Study of Chemo-Immunotherapy in Head and Neck Cancer Patients#249583ClinicalTrials.gov
• Prehabilitation Protocol for Head and Neck Cancer Patients#814008ClinicalTrials.gov
• Swallowing Rehabilitation in Patients With Head and Neck Cancer Receiving Radiotherapy#830835ClinicalTrials.gov
• Observational Study on Biomarkers in Head and Neck Cancer (HNprädBio)#836145ClinicalTrials.gov
• Docetaxel in Head and Neck Cancer#904670ClinicalTrials.gov
• A Comprehensive Approach to Head and Neck Cancer Prehabilitation#852147ClinicalTrials.gov
• Epacadostat and Pembrolizumab in Patients With Head and Neck Cancer That Have Failed Prior Immunotherapy#668811ClinicalTrials.gov
• Metronomic Chemotherapy With Tegafur/Uracil for Head and Neck Squamous Cell Carcinoma#873480ClinicalTrials.gov
• HYperfractionated Radiation Therapy Versus Concurrent Chemoradiation for Head and Neck Cancer (HYTC)#917514ClinicalTrials.gov
• Head and Neck Cancer Treatment Related Dysphagia#890418ClinicalTrials.gov
• Quality of Life in Head and Neck Patients#363613ClinicalTrials.gov
• T-cell Based Immunotherapy for Head and Neck Cancer#172295ClinicalTrials.gov
• Quality of Life in Patients Treated for Head and Neck Cancer#888769ClinicalTrials.gov
• Prognostic Markers for a Better Follow-up in Head and Neck Cancer.#1009796ClinicalTrials.gov
• Post-Radiation Oral Health in Underserved Head and Neck Cancer Patients#887213ClinicalTrials.gov
• Phase 3 Study of PDS0101 and Pembrolizumab in HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma#208444ClinicalTrials.gov
• Definitive Chemo-Radiotherapy for Regionally Advanced Head and Neck Cancer With or Without Up-front Neck Dissection#804697ClinicalTrials.gov
• Activity and Safety Study of BKM120 in Monotherapy in Patient With Metastatic Head and Neck Cancer Recurrent or Progressive#800378ClinicalTrials.gov
• Potentiation of Cetuximab by Tregs Depletion With CSA in Advanced Head & Neck Cancer#832236ClinicalTrials.gov
• Cisplatin, Nab-Paclitaxel, and Cetuximab (CACTUX) in Patients With Incurable Head and Neck Squamous Cell Carcinoma#880783ClinicalTrials.gov
• Feasibility and Preliminary Efficacy of Hatha Yoga in Head and Neck Cancer Survivors#980201ClinicalTrials.gov
• Exercise and Nutrition for Head and Neck Cancer Patients#882046ClinicalTrials.gov
• Preoperative Pembrolizumab and Chemotherapy in Resectable, Recurrent HNSCC#979420ClinicalTrials.gov
• Cetuximab (ERBITUX®) Added to Two Concurrent Chemoradiotherapy Platforms in Locally Advanced Head and Neck Cancer#891093ClinicalTrials.gov
• The Role of Dietary Fiber in Mitigating Sarcopenia Risk in Head and Neck Cancer#802121ClinicalTrials.gov
• Prognostic Evaluation of 18fmiso Pet-ct in Head and Neck Cancer#867288ClinicalTrials.gov
• ASP-1929 Photoimmunotherapy (PIT) Study in Patients With Recurrent Head/Neck Cancer#918403ClinicalTrials.gov
• CLR 131 Combined With Radiation for Head and Neck Cancer#840471ClinicalTrials.gov
• Discovering Factors in Head and Neck Cancer Patients' Clinical Study Experiences#979430ClinicalTrials.gov